Sevcan Alkan Kayaoglu

Sevcan Alkan Kayaoglu

Auto-generated profile, based on publicly available information

Sevcan Alkan Kayaoglu

Haydarpasa Numune Training and Research Hospital, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SKSevcan Alkan Kayaoglu
Sevcan Alkan Kayaoglu
MTMetin Tilki
Metin Tilki
The treatment for patients with acute calculous cholecystitis who have high surgical risk with percutaneous cholecystostomy instead of surgery is an appropriate alternative choice. The aim of this study was to examine the promising percutaneous cholecystostomy intervention to share our experiences about the duration of catheter that has yet to be determined. A total of 163 patients diagnosed with acute calculous cholecystitis and treated with percutaneous cholecystostomy between January 2011 and July 2020 were reviewed retrospectively. The Tokyo Guidelines 2018 were used to diagnose and grade patients with acute cholecystitis. The mean age was 71.81±12.81 years. According to the Tokyo grading, 143 patients had grade 2 and 20 patients had grade 3 disease. The mean duration of catheter was 39.12±37 (1-270) days. Minimal bile leakage into the peritoneum was noted in 3 (1.8%) patients during the procedure. The rate of complications during follow-up of the patients who underwent percutaneous cholecystostomy was 6.9% (n=11), and the most common complication was catheter dislocation. Cholecystectomy was performed in 33.1% (n=54) of the patients at follow-up. Post-cholecystectomy complication rate was 12.9%. At the follow-up, the rate of recurrent acute cholecystitis episodes was 5.5%, while the mortality rate was 1.8%. The length of follow-up was five years. The rate of recurrence was significantly higher among the patients with catheter for <21 days. We recommend that the duration of catheter should be minimum 21 days in patients undergoing percutaneous cholecystostomy.

1 February 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SKSevcan Alkan Kayaoglu
Sevcan Alkan Kayaoglu
OSozlem sert
ozlem sert
OBJECTIVE: COVID-19 outbreak has become widespread globally and caused a new global chaos. This outbreak that completely affected the lifestyle of individuals resulted in periods of isolation. Here, we evaluated the effects of lifestyle changes with isolation on constipation. METHODS: A survey on constipation was performed during the 12-week isolation period starting in March 2020 in Turkey. Data of 390 individuals who participated in the survey through the social media and who were actively employed prior to isolation were analyzed. Rome IV criteria were used to evaluate constipation. RESULTS: Among the participants in the study, 253 (64.9%) were women with the mean age of 39.5 +/- 9.5 years. A statistically significant association was found between the decreased water consumption during the isolation period and constipation after the isolation (p=0.020; p<0.05). A significant association was found between the changes in physical activity and constipation after the isolation (p=0.013; p<0.05). New development of constipation during the isolation or declaration of increased constipation was found to be statistically associated with post-isolation constipation according to Rome criteria (p=0.000; p<0.05). CONCLUSION: The data of this present study demonstrated that isolation period was effective on the newly developed constipation. Decreased physical activity and water consumption are also effective on constipation.

1 December 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
MUMehmet Ali Uzun
Mehmet Ali Uzun
MTMetin Tilki
Metin Tilki
SKSevcan Alkan Kayaoğlu
Sevcan Alkan Kayaoğlu
GOGülten Çiçek Okuyan
Gülten Çiçek Okuyan
ZKZeynep Gamze Kılıçoğlu
Zeynep Gamze Kılıçoğlu
AGAylin Gönültaş
Aylin Gönültaş
Objective: Gallbladder cancer is relatively rare and traditionally regarded as having poor prognosis. There is controversy about the effects of clinicopathological features and different surgical techniques on prognosis. The aim of this study was to investigate the effects of clinicopathological characteristics of the patients with surgically treated gallbladder cancer on long-term survival. Material and Methods: We retrospectively analyzed the database of gallbladder cancer patients treated at our clinic between January 2003 and March 2021. Results: Of 101 evaluated cases, 37 were inoperable. Twelve patients were determined unresectable based on surgical findings. Resection with curative intent was performed in 52 patients. The one-, three-, five-, and 10-year survival rates were 68.9%, 51.9%, 43.6%, and 43.6%, respectively. Median survival was 36.6 months. On univariate analysis, poor prognostic factors were determined as advanced age; high carbohydrate antigen 19-9 and carcinoembryonic antigen levels; non-incidental diagnosis; intraoperative incidental diagnosis; jaundice; adjacent organ/structure resection; grade 3 tumors; lymphovascular invasion; and high T, N1 or N2, M1, and high AJCC stages. Sex, IVb/V segmentectomy instead of wedge resection, perineural invasion, tumor location, number of resected lymph nodes, and extended lymphadenectomy did not significantly affect overall survival. On multivariate analysis, only high AJCC stages, grade 3 tumors, high carcinoembryonic antigen levels, and advanced age were independent predictors of poor prognosis. Conclusion: Treatment planning and clinical decision-making for gallbladder cancer requires individualized prognostic assessment along with standard anatomical staging and other confirmed prognostic factors.

1 May 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MUMehmet Ali Uzun
Mehmet Ali Uzun
MTMetin Tilki
Metin Tilki
AGAylin Gönültaş
Aylin Gönültaş
FAFügen Aker
Fügen Aker
SKSevcan Alkan Kayaoglu
Sevcan Alkan Kayaoglu
GOGülten Çiçek Okuyan
Gülten Çiçek Okuyan
OBJECTIVE: This study aimed to examine the prognostic effect of the tumor-stroma ratio, which has been shown to have prognostic value in various cancers, in patients with gallbladder cancer who have undergone curative resection. METHODS: The records of gallbladder cancer patients who underwent surgical treatment in our clinic between December 2005 and March 2021 were analyzed retrospectively. The hematoxylin and eosin-stained sections representing the tumors were evaluated under light microscopy to determine tumor-stroma ratio, and based on the results, <50% was defined as the stroma-rich and ???50% as the stroma-poor groups. RESULTS: A total of 28 patients, including 20 females and 8 males, with a mean age of 64.6 years, were included in this study. Stroma-poor and stromarich tumors were detected in 15 and 13 patients, respectively. There was no statistically significant relationship identified between tumor-stroma ratio and advanced age, gender, serum levels of carbohydrate antigen 19-9 and carcinoembryonic antigen, incidental or nonincidental diagnosis, jaundice, adjacent organ or structure resection, tumor location, grades 1???2 or 3, T1/T2 or T3/T4, N0 or N1/N2, M stage, American Joint Committee on Cancer stage, lymphovascular invasion, and perineural invasion. The stroma-poor and stroma-rich groups had a 5-year survival rate of 30% and 19.2% and a median overall survival of 25.7 and 15.1 months, respectively, with no statistically significant difference between the groups (p=0.526). CONCLUSIONS: A low tumor-stroma ratio tended to be a poor prognostic factor in gallbladder cancer, although not to a statistically significant degree. This can be considered one of the preliminary studies, as further studies involving larger groups are needed.

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
SKSevcan Alkan Kayaoğlu
Sevcan Alkan Kayaoğlu
MUMehmet Ali Uzun
Mehmet Ali Uzun
DEDoğan Erdoğan
Doğan Erdoğan
INTRODUCTION:Pancreaticoduodenectomy is a highly complex procedure that requires surgical experience.. Among these is the use of a stapler in the construction of the gastrojejunostomy anastomosis during the procedure. Our study compares the patient outcomes of gastrojejunostomy anastomosis procedures performed manually and with a circular stapler. MATERIALS AND METHOD:Our study retrospectively evaluated the data of 44 patients who had undergone pancreaticoduodenectomy performed by the same surgical team between May 2015 and December 2019. The manual gastrojejunostomy anastomosis(n = 32) and stapled (circular stapler 25 millimeter) anastomosis(n=12) patient groups were compared for anastomotic stricture. RESULTS:Of the 44 patients undergoing pancreaticoduodenectomy, 68.2% were male, the mean age was 62.9±12.1 years and the mean follow-up was 28.2±21.2 months. The rate of gastrojejunostomy stricture was significantly higher in the circular stapler group (p = 0.017;p < 0.05). CONCLUSION:The increased risk of postoperative pancreatic fistula and anastomotic stricture prevents us from recommending the use of a circular-stapler in the creation of the gastrojejunostomy anastomosis in pancreaticoduodenectomy procedures, as it increases the risk of postoperative pancreatic fistula and anastomotic stricture, and provides no operative time advantage.

7 July 2021 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
SKSevcan Alkan Kayaoğlu
Sevcan Alkan Kayaoğlu
MUMehmet Ali Uzun
Mehmet Ali Uzun
AMAÇ: AP pankreasın akut inflamatuar bir hastalığıdır. Hastaların çoğunda hafif seyrederken, yaklaşık %10-20’sinde şiddetli seyredip ciddi morbidite ve mortalite riski taşır. Şiddetli AP hastalarının, uygun merkezlerde ve gereğinde yoğun bakım ünitelerinde yapılan erken agresif tedavisi ile morbidite ve mortalite düşürülebilmekte olup AP şiddetini erken ve güvenilir bir şekilde ön görebilmek önemlidir. GEREÇ VE YÖNTEMLER: Bu çalışmada, AP şiddetini öngörmede BISAP skoru ile APACHE II skorunun karşılaştırılması amaçlandı. Bu amaçla mart 2015 - temmuz 2016 arasında tedavi ettiğimiz 86 AP hastası çalışmaya alındı. Hastaların ortalama yaşı 52,33 olup 48’i (%55,8) kadındı. Revize Atlanta kriterlerine göre 58 (%67,4) hastada hafif, 20 (%23,3) hastada orta şiddette ve 8 (%9,3) hastada şiddetli AP saptandı. Şiddetli AP olan bir hasta eksitus oldu. Genel mortalite %1,16 ve şiddetli AP için mortalite %12,5 idi. BULGULAR:Hastalar başvuruda, 24. saat ve 48. saatte APACHE II ve ilk 24 saatte BISAP skorlaması ile değerlendirildi. BISAP skorlamasında ≥2 olan 11 (%12,8) hastanın 5’i (%45,45) şiddetli AP, 5’i orta şiddette AP ve 1’ide (%9,09) hafif AP idi. BISAP skoru <2 olan 75 hastanın ise sadece 3’ünde (%4) şiddetli AP saptandı. Başvuruda APACHE II skoru ≥8 olan 9 (%10,5) hastanın 6’sı (%66,7) şiddetli AP, 3’ü ise orta şiddette AP idi. Skoru <8 olan 77 hastanın ise sadece 3’ünde (%2,6) şiddetli AP saptandı. 24. ve 48. saat APACHE II skoru ≥8 olan 4 hastanın (%4,7) tamamı şiddetli AP idi. Şiddetli AP gelişmesinin BISAP ile öngörülmesinde duyarlılık %62,50; özgüllük % 92,31; pozitif prediktif değer %45,45 ve negatif prediktif değer %96 olarak saptandı. Şiddetli AP gelişmesinin APACHE II ile öngörülmesinde; başvurudaki APACHE II için duyarlılık %75; özgüllük % 96,15; pozitif prediktif değer %66,67 ve negatif prediktif değer %97,40 iken 24. saat ve 48. saat APACHE II için duyarlılık %50; özgüllük % 100; pozitif prediktif değer %100 ve negatif prediktif değer %95,12 olarak saptandı. SONUÇLAR: Çalışmamızda AP’in şiddetini öngörmede BISAP skorlaması ile gerek başvuruda gerekse 24. ve 48. saat APACHE II skorlamaları arasında istatistiksel anlamlı pozitif korelasyon saptandı. Etkinlikleri değerlendirildiğinde de benzer doğrulukta oldukları görüldü. Sonuç olarak; BISAP skorlamasının AP şiddetini öngörmede, uygulaması zor ve karmaşık bir yöntem olan APACHE II skorlaması yerine daha kolay ve basit bir yöntem olarak uygulanabileceğini düşünmekteyiz.